Simon J. Adamson
YOU?
Author Swipe
View article: Psychometric Performance of the Cannabis Use Disorders Identification Test– Revised (CUDIT-R) in an Youth Clinical Sample
Psychometric Performance of the Cannabis Use Disorders Identification Test– Revised (CUDIT-R) in an Youth Clinical Sample Open
The Cannabis Use Disorders Identification Test–Revised (CUDIT-R) is an eight-item screening tool designed to identify problematic cannabis use. The present study intended to assess the psychometric properties of the measure in a youth samp…
View article: Association of bradykinin receptor 2 (BDKRB2) variants with physical performance and muscle mass: Findings from the LACE sarcopenia trial
Association of bradykinin receptor 2 (BDKRB2) variants with physical performance and muscle mass: Findings from the LACE sarcopenia trial Open
Introduction Understanding genetic contributors to sarcopenia (age-related loss of muscle strength and mass) is key to finding effective therapies. Variants of the bradykinin receptor 2 (BDKRB2) have been linked to athletic and muscle perf…
View article: Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes
Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes Open
BACKGROUND Currently available semiautomated insulin-delivery systems require individualized insulin regimens for the initialization of therapy and meal doses based on carbohydrate counting for routine operation. In contrast, the bionic pa…
View article: Activin type I receptor polymorphisms and body composition in older individuals with sarcopenia—Analyses from the LACE randomised controlled trial
Activin type I receptor polymorphisms and body composition in older individuals with sarcopenia—Analyses from the LACE randomised controlled trial Open
Background Ageing is associated with changes in body composition including an overall reduction in muscle mass and a proportionate increase in fat mass. Sarcopenia is characterised by losses in both muscle mass and strength. Body compositi…
View article: ACE I/D genotype associates with strength in sarcopenic men but not with response to ACE inhibitor therapy in older adults with sarcopenia: Results from the LACE trial
ACE I/D genotype associates with strength in sarcopenic men but not with response to ACE inhibitor therapy in older adults with sarcopenia: Results from the LACE trial Open
Background Angiotensin II (AII), has been suggested to promote muscle loss. Reducing AII synthesis, by inhibiting angiotensin converting enzyme (ACE) activity has been proposed as a method to inhibit muscle loss. The LACE clinical trial wa…
View article: The New Zealand drug harms ranking study: A multi-criteria decision analysis
The New Zealand drug harms ranking study: A multi-criteria decision analysis Open
Aims: The harms arising from psychoactive drug use are complex, and harm reduction strategies should be informed by a detailed understanding of the extent and nature of that harm. Drug harm is also context specific, and so any comprehensiv…
View article: Index
Index Open
Journal of Ultrasound in MedicineVolume 42, Issue S1 p. S265-S270 Author Index Index First published: 19 June 2023 https://doi.org/10.1002/jum.16260Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack cita…
View article: Leucine and perindopril to improve physical performance in people over 70 years with sarcopenia: the LACE factorial RCT
Leucine and perindopril to improve physical performance in people over 70 years with sarcopenia: the LACE factorial RCT Open
Background Angiotensin-converting enzyme inhibitors and leucine are promising potential treatments for sarcopenia. Neither has yet been tested in adequately powered randomised trials in patients with sarcopenia. Objectives To determine the…
View article: 667 EFFECT OF LEUCINE SUPPLEMENTATION ON PHYSICAL PERFORMANCE, MUSCLE MASS AND QUALITY OF LIFE IN OLDER PEOPLE WITH SARCOPENIA
667 EFFECT OF LEUCINE SUPPLEMENTATION ON PHYSICAL PERFORMANCE, MUSCLE MASS AND QUALITY OF LIFE IN OLDER PEOPLE WITH SARCOPENIA Open
Introduction Leucine supplementation improves muscle protein synthesis in physiological studies and has been proposed as a treatment to improve muscle mass and physical performance. We tested the effects of leucine supplementation in a ran…
View article: 666 EFFECT OF PERINDOPRIL ON PHYSICAL PERFORMANCE, MUSCLE MASS AND QUALITY OF LIFE IN OLDER PEOPLE WITH SARCOPENIA: RESULTS: FROM THE
666 EFFECT OF PERINDOPRIL ON PHYSICAL PERFORMANCE, MUSCLE MASS AND QUALITY OF LIFE IN OLDER PEOPLE WITH SARCOPENIA: RESULTS: FROM THE Open
Introduction Angiotensin-converting enzyme inhibitors such as perindopril have been proposed as treatments to improve muscle mass and physical performance but have not been tested in randomised controlled trials enrolling patients with sar…
View article: Preliminary Development of a Brief Cannabis Use Disorder Screening Tool: The Cannabis Use Disorder Identification Test Short-Form
Preliminary Development of a Brief Cannabis Use Disorder Screening Tool: The Cannabis Use Disorder Identification Test Short-Form Open
Introduction: Rates of cannabis use disorder (CUD) among vulnerable populations have increased in recent years, highlighting a need to equip providers with an efficient screening tool. Materials and Methods: A short form of the Cannabis Us…